Synthesis and biological evaluation of novel technetium-99mlabeled HYNIC-D-glucose as a potential tumor imaging agent.

Synthesis and biodistribution of 99mTc-HYNIC-DG as a novel potential tumor imaging agent.

A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.

Metastatic melanoma targeting property of a novel Tc-99m-labeled HYNIC-conjugated lactam bridge-cyclized alpha-MSH peptide.

Synthesis and biodistribution of 99mTcN-thymidine dithiocarbamate as a potential tumor imaging agent.

Effects of the Arg-Pro and Gly-Gly-Nle Moieties on Melanocortin-1 Receptor Binding Affinities of α-MSH Peptides.

Synthesis and biodistribution of a novel 99mTc complex of HYNIC-Conjugated thymidine as a potential tumor imaging agent.

Synthesis and biological evaluation of a novel 99mTc complex of HYNIC-conjugated aminomethylenediphos-phonate as a potential bone imaging agent.

Synthesis and biodistribution of a novel 99mTc complex of HYNIC-conjugated metronidazole as a potential tumor hypoxia imaging agent.

Preparation, characterization and biodistribution of new technetium-99m complexes with DMP-AMDP and DMP-ACPDP.